Inicio>>Signaling Pathways>> Cell Cycle/Checkpoint>> ECM & Adhesion Molecules>>Arg-Gly-Asp (trifluoroacetate salt)

Arg-Gly-Asp (trifluoroacetate salt) (Synonyms: RGD)

Catalog No.GC52474

A synthetic peptide corresponding to an integrin cell adhesion sequence

Products are for research use only. Not for human use. We do not sell to patients.

Arg-Gly-Asp (trifluoroacetate salt) Chemical Structure

Cas No.: 120103-89-1

Tamaño Precio Disponibilidad Cantidad
5 mg
99,00 $
Disponible
10 mg
158,00 $
Disponible
25 mg
297,00 $
Disponible
50 mg
543,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Arg-Gly-Asp (RGD) is a synthetic peptide corresponding to the cell adhesion sequence for the integrins αVβ1, αVβ3, αVβ5, αVβ6, αVβ8, α8β1, and α5β1.1,2 It is a component of radioligands and peptidomimetics that have been used in the study of integrin expression and activity in vivo.2,3

1.Ruoslahti, E.RGD and other recognition sequences for integrinsAnnu. Rev. Cell Dev. Biol.12697-715(1996) 2.Danhier, F., Le Breton, A., and PrÉat, V.RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosisMol. Pharm.9(11)2961-2973(2012) 3.Schottelius, M., Laufer, B., Kessler, H., et al.Ligands for mapping αvβ3-integrin expression in vivoAcc. Chem. Res.42(7)969-980(2009)

Reseñas

Review for Arg-Gly-Asp (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Arg-Gly-Asp (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.